Influence of prebiotics on the human immune system (GALT)

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 2, Issue 2, 2008, Pages 149-153

  Bodera, Pawel ^a  

^a Natur Produkt Zdrovit Ltd   (Poland)

Author keywords

Allergy; Autoimmune disease; Gut associated lymphoid tissues (GALT); Immune modulation; Prebiotics

Indexed keywords

ARABINOGALACTAN; FRUCTOSE OLIGOSACCHARIDE; INULIN; MANNOSE OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ATOPY; AUTOIMMUNE DISEASE; BACTERIAL FLORA; BACTERIAL GROWTH; BACTERIAL STRAIN; CLINICAL TRIAL; COLITIS; COLORECTAL CANCER; CROHN DISEASE; DIARRHEA; DRUG ACTIVITY; ENTERITIS; ENTEROPATHY; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; INTESTINE FUNCTION; INTESTINE LYMPHATIC TISSUE; IRRITABLE COLON; LACTASE DEFICIENCY; NONHUMAN; PANCREATITIS; PATENT; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ANIMALS; GALACTANS; HUMANS; IMMUNITY; INTESTINES; INULIN; LYMPHOID TISSUE; OLIGOSACCHARIDES; PATENTS AS TOPIC; PROBIOTICS;

EID: 55849089244     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221308784543656     Document Type: Review

References (26)

1. Gibson GR, Roberfroid MB. Dietary modulation of the colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-1412.
2. Gibson GR, Probert HM, Van Loo JAE, Roberfroid MB. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr Res Rev 2004; 17: 257-259.
3. Roberfroid MB, Delzenne NM. Dietary fructans. Annu Rev Nutr 1998; 18: 117-143.
4. Pierre F, Perrin P, Champ M, et al. Short-chain fructooligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res 1997; 57: 225-228.
5. Bielecka M, Biedrzycka E, Majkowska A. Selection of probiotics and prebiotics for synbiotics and confirmation of their in vivo effectiveness. Food Res Int 2002; 35: 139-144.
6. Cummings JH, MacFarlane G. Gastrointestinal effects of prebiotics. Br J Nutr 2002; 87: 145-S51.
7. Fooks LJ, Gibson GR. in vitro Investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol Ecol 2002; 39: 67-75.
8. Asahara T, Nomoto K, Shimizu K, et al. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. J Appl Microbiol 2001; 91: 985-996.
9. Bomba A, Nemcova R, Gancarcikova S, Herich R, Guba P, Mudronova D. Improvement of the probiotic effect of microorganisms by their combination with maltodextrins, fructooligosaccharides and polyunsaturated fatty acids. Br J Nutr 2002; 88: 95-99.
10. Videla S, Vilaseca J, Antoln M, et al. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol. 2001; 96: 1486-1493.
11. Fukuda M, Kanauchi O, Araki Y, et al. Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int J Mol Med 2002; 9: 65-70.
12. Holma R, Juvonen P, Asmawi MZ, et al. Galacto-oligosaccharides stimulate the growth of Bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand J Gastroenterol 2002; 37: 1042-1047.
13. Cherbut C. Inulin and oligofructose in the dietary fi bre concept. Br J Nutr 2002; 87 (2): 159-162.
14. Hill MJ. The normal gut bacterial flora, Role of gut bacteria in human toxicology and pharmacology. In M. J. Hill Ed., Taylor and Francis Ltd., London United Kingdom. 1995; 3-17.
15. Hopkins MJ, Sharp R, MacFarlane G. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48 (2): 198-205.
16. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995; 78 (3): 491-497.
17. Steed H, MacFarlane GT, Macfarlane S. Prebiotics, synbiotics and inflammatory bowel disease. Mol Nutr Food Res 2008; 16: 13-25. http://dx.doi.org/10.1002/mnfr.200700139
18. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomized controlled pilot trial. Gut 2006; 54: 242-249.
19. Roller M, Rechkemmer G, Watzl B, et al. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Brit. F Nutr 2007; 97: 676-684.
20. Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680.
21. Abreu MT. Immunologic regulation of toll-like receptors in gut epithelium. Curr Opin Gastroenterol 2003; 19: 559-564.
22. Crum, A.B., Zivkovic, D.D.: US013218 (1999).
23. Meydani SN. Status of Nutritional Immunology Studies. J Nutr Immunol 1994; 2: 93-97.
24. Rochat, F., Schifferin, E., Guigoz, Y.: EP1383514 (2004).
25. Naidu, S.A., Baksh, B.: US20040223956 (2004).
26. Garn, H., Bluemer, N., Renz, H., Herz, U.: US20075032399 (2007).